Search Results 341-350 of 13607 for monoclonal antibody
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...
Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...
Therapies include monoclonal antibodies and proteasome inhibitors. Corticosteroids. Corticosteroid medicines such as dexamethasone work directly against ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
Our chronic migraine treatment uses VYEPTI infusions, delivered intravenously. VYEPTI is a monoclonal antibody that targets calcitonin gene-related peptide ...
It is a monoclonal antibody. Tocilizumab injection is also used alone or together with glucocorticoids (steroid medicine) to treat giant cell arteritis ...
Trastuzumab-anns is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Monoclonal antibodies, such as rituximab, interfere with the ability of cancer cells to grow and spread. It is not yet known whether fludarabine phosphate ...
Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.